Covid-19 Vaccine Opportunities Worth $10-11 Billion For The Indian Pharma Sector

The Indian pharmaceutical sector is expected to manufacture sufficient Covid-19 vaccines to meet the domestic demand. CARE Ratings expects majority of the domestic demand to be fulfilled latest by March 2022, by which time the export opportunities in the high-income markets

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3iZ5A5B